UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores

Therapeutic advances in endocrinology and metabolism, 2021, Vol.12, p.2042018820974191-2042018820974191

2021

Volltextzugriff (PDF)

Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers

Frontiers in pharmacology, 2022-01, Vol.12, p.786706

2022

Volltextzugriff (PDF)

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure

Cardiovascular diabetology, 2022-09, Vol.21 (1), p.1-194, Article 194

2022

Volltextzugriff (PDF)

Comparison of nurses and general caregivers’ knowledge, attitude, and practice on medication administration process and their distress level in long-term care facilities across Penang, Kuala Lumpur, and Selangor of Malaysia

Aging clinical and experimental research, 2018-02, Vol.30 (2), p.183-191

2018

Volltextzugriff (PDF)

Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers

Frontiers in pharmacology, 2022-04, Vol.13, p.786767-786767

2022

Volltextzugriff (PDF)

Precision medicine approaches for diabetic kidney disease: opportunities and challenges

Nephrology, dialysis, transplantation, 2021-06, Vol.36 (Supplement_2), p.ii3-ii9

2021

Volltextzugriff (PDF)

Ephrin Signaling and the Development of Early Progressive Kidney Function Decline: TH-OR48

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

Effects of GLP-1 Receptor Agonist Dulaglutide on Profile of Circulating miRNAs Associated with ESKD in Type 2 Diabetes: TH-OR59

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.18-18

2023

Volltextzugriff (PDF)

Impact of DNA Methylation Variation on Risk of Kidney Failure in Type 1 Diabetes Is Mediated through Increased Levels of Circulating Proteins: FR-PO253

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

Assessing Heterogeneity of Treatment Effects from Canagliflozin (CANA) on Kidney Outcomes Using the Joslin Kidney Panel: Insights from the CREDENCE Trial: FR-PO321

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

Global Proteomic Search for Circulating Proteins Associated with Albuminuria in Patients with Diabetic Kidney Disease: TH-PO175

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.137-138

2023

Volltextzugriff (PDF)

Erratum to: Precision medicine approaches for diabetic kidney disease: opportunities and challenges

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (6), p.1198-1198

2022

Volltextzugriff (PDF)

FC 125DIURETIC USE IS ASSOCIATED WITH INCREASED RISK FOR POSTTRANSPLANTATION DIABETES MELLITUS IN RENAL TRANSPLANT RECIPIENTS

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

AWARD-7 Post Hoc Analysis: Circulating Proteins Measured by Joslin Kidney Panel Identify Dulaglutide Responders: TH-PO168

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.135-135

2023

Volltextzugriff (PDF)

The importance of targeting multiple risk markers in patients with type 2 diabetes: A post‐hoc study from the CANVAS programme

Diabetes, obesity & metabolism, 2023-06, Vol.25 (6), p.1638-1645

2023

Volltextzugriff (PDF)

Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients

Nephrology, dialysis, transplantation, 2022-06, Vol.37 (7), p.1375-1383

2022

Volltextzugriff (PDF)

7358 Profile of Circulating miRNAs Associated with Body Weight Reduction in Type 2 Diabetes Patients Treated with GLP-1 Receptor Agonist Dulaglutide: Secondary Analysis of AWARD-7 Trial

Journal of the Endocrine Society, 2024-10, Vol.8 (Supplement_1)

2024

Volltextzugriff (PDF)

Prevalence, factors associated and coping strategies of stress among pharmacy students in a public university in Malaysia

Pharmacy & Pharmacology International Journal, 2020-03, Vol.8 (2), p.64-71

2020

Volltextzugriff (PDF)

Translation and validation of revised illness perception questionnaire (IPQ-R): The Malay version in Malaysia

Health Education and Care, 2019, Vol.4 (1)

2019

Volltextzugriff (PDF)

Biomarkers and Precision Medicine in Diabetes

Textbook of Diabetes, 2024, p.414-428

2024

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(19)
Buchkapitel
(1)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores

Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure

Comparison of nurses and general caregivers’ knowledge, attitude, and practice on medication administration process and their distress level in long-term care facilities across Penang, Kuala Lumpur, and Selangor of Malaysia

Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers

Precision medicine approaches for diabetic kidney disease: opportunities and challenges

Ephrin Signaling and the Development of Early Progressive Kidney Function Decline: TH-OR48

Effects of GLP-1 Receptor Agonist Dulaglutide on Profile of Circulating miRNAs Associated with ESKD in Type 2 Diabetes: TH-OR59

Impact of DNA Methylation Variation on Risk of Kidney Failure in Type 1 Diabetes Is Mediated through Increased Levels of Circulating Proteins: FR-PO253

Assessing Heterogeneity of Treatment Effects from Canagliflozin (CANA) on Kidney Outcomes Using the Joslin Kidney Panel: Insights from the CREDENCE Trial: FR-PO321

Global Proteomic Search for Circulating Proteins Associated with Albuminuria in Patients with Diabetic Kidney Disease: TH-PO175

Erratum to: Precision medicine approaches for diabetic kidney disease: opportunities and challenges

FC 125DIURETIC USE IS ASSOCIATED WITH INCREASED RISK FOR POSTTRANSPLANTATION DIABETES MELLITUS IN RENAL TRANSPLANT RECIPIENTS

AWARD-7 Post Hoc Analysis: Circulating Proteins Measured by Joslin Kidney Panel Identify Dulaglutide Responders: TH-PO168

The importance of targeting multiple risk markers in patients with type 2 diabetes: A post‐hoc study from the CANVAS programme

Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients

7358 Profile of Circulating miRNAs Associated with Body Weight Reduction in Type 2 Diabetes Patients Treated with GLP-1 Receptor Agonist Dulaglutide: Secondary Analysis of AWARD-7 Trial

Prevalence, factors associated and coping strategies of stress among pharmacy students in a public university in Malaysia

Translation and validation of revised illness perception questionnaire (IPQ-R): The Malay version in Malaysia

Biomarkers and Precision Medicine in Diabetes

Suchergebnisse filtern